AI and Rare Diseases ── 2026-11-17

New papers on rare diseases (other than neurological and cancer) and AI, collected from journal feeds, PubMed (searched across all journals) and OpenAlex (a public index used instead of Google Scholar), judged by Jev (an AI that makes language judgements): original research, AI central, which of 8 disease groups, treatment or trials, and then ranked by importance up to a daily limit. Journals are not filtered by impact factor; each paper shows its journal's IF-equivalent (OpenAlex two-year mean citedness) and the date of that value. Each entry shows the full original abstract.
Read by disease: Platforms(1) · Inborn errors of metabolism(0) · Genetic syndromes(0) · Rare blood disorders(0) · Immune and connective tissue(0) · Heart and lung(0) · Kidney, liver and gut(0) · Skin and bone(0)
Rare-disease diagnosis and drug discovery platforms and AI
- Abstract
Representation learning in genomics often relies on sequence, expression, and network data, thereby overlooking a wealth of insights in the scientific literature. Here, we present LitGene, an interpretable transformer-based model that refines gene representations by integrating unstructured textual information with Gene Ontology annotations through contrastive learning. In evaluations across eight benchmark tasks for protein properties, LitGene achieves competitive accuracy and exhibits zero-shot prediction of GO terms, KEGG pathways, and gene-disease associations. LitGene identified ANGPTL6 as a potential candidate gene for idiopathic pulmonary fibrosis (IPF), supported by its differential expression in independent IPF samples, illustrating LitGene's utility for hypothesis generation. A SHAP-based interpretability tool highlights text features influencing predictions, while an automated literature-grounding framework provides corroborating support where available. Our results suggest that integrating textual and genetic information may help reduce biases associated with under-studied genes. The model is released as open-source code, along with a publicly accessible web interface at https://litgene.cs.unm.edu/ , which allows users to submit gene names, disease names, drug names, or custom text (e.g., publication abstracts) to obtain evidence-based predictions of related biomedical entities.
Journal IF-equivalent: 19.8 (OpenAlex 2-year mean citedness, value as of 2026-11-16, retrieved 2026-11-17; not the official Clarivate IF)Reference: Macaulay O, Jararweh A, Arredondo D, Tafoya LE, Poshiya S, Hu Y, et al. LitGene: an interpretable transformer model integrating text and ontology for gene representation learning. Nat Commun. 2026 Oct 16;17(1):11706. doi:10.1038/s41467-026-78454-4. PMID: 43035455.Checked: Abstract only
Inborn errors of metabolism: treatment, trials and AI
No new qualifying paper for this issue.
Genetic syndromes and paediatric rare diseases: treatment, trials and AI
No new qualifying paper for this issue.
Rare blood disorders: treatment, trials and AI
No new qualifying paper for this issue.
Autoinflammatory, immunodeficiency and rare connective-tissue diseases: treatment, trials and AI
No new qualifying paper for this issue.
Rare cardiovascular and respiratory diseases: treatment, trials and AI
No new qualifying paper for this issue.
Rare kidney, liver and gastrointestinal diseases: treatment, trials and AI
No new qualifying paper for this issue.
Rare skin and bone diseases: treatment, trials and AI
No new qualifying paper for this issue.